Association between abnormal IMDC laboratory criteria after surgery and cancer-specific and overall survival in non-metastatic renal cell carcinoma: Potential biomarkers for adjuvant therapy patient ...
Serum biomarkers in metastatic castration-resistant prostate cancer (mCRPC) patients receiving [177Lu]Lu-PSMA-617 therapy: Post hoc analysis of a phase II clinical trial. Individual patient data (IPD) ...
Application of canary histology classifier in prostate biopsies for risk stratification. Decipher genomic classifier (DGC) of early prostate cancer (EPC), and underlying transcriptomic profile (TP): ...
Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in Solutions In 467 consecutive patients with ALL (0-20 years), we ...
Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML ...